| Celeste S Long, MD | |
|
1300 Wesley Dr, Memphis, TN 38116 | |
| (901) 395-2618 | |
| (901) 385-3261 |
| Full Name | Celeste S Long |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 35 Years |
| Location | 1300 Wesley Dr, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538185889 | NPI | - | NPPES |
| 4045056 | Other | TN | BCBS OF TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 21442 (Tennessee) | Secondary |
| 207R00000X | Internal Medicine | MD21442 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Methodist Inpatient Physicians Llc | 1254241235 | 112 |
| Methodist Inpatient Physicians Llc | 1254241235 | 112 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Children's Health Fund strongly supports the reconciliation bill signed by President Barack Obama implementing positive changes and fixes to the health reform bill he signed earlier this week. This second piece of health reform legislation marks an unprecedented effort to make real and positive change for the health and well-being of children in this country.
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Squire, Sanders & Dempsey is launching Accountable Care Forum - From Volume to Value, a blog dedicated to analysis of the emerging accountable care organization landscape. The launch coincides with regulations issued today by the Centers for Medicare & Medicaid Services.
Tandem Diabetes Care, Inc. , a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2 Insulin Pump with Basal-IQ™ Technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia).
› Verified 3 days ago
| Entity Name | Methodist Inpatient Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609850692 PECOS PAC ID: 1254241235 Enrollment ID: O20050815000700 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Children's Health Fund strongly supports the reconciliation bill signed by President Barack Obama implementing positive changes and fixes to the health reform bill he signed earlier this week. This second piece of health reform legislation marks an unprecedented effort to make real and positive change for the health and well-being of children in this country.
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Squire, Sanders & Dempsey is launching Accountable Care Forum - From Volume to Value, a blog dedicated to analysis of the emerging accountable care organization landscape. The launch coincides with regulations issued today by the Centers for Medicare & Medicaid Services.
Tandem Diabetes Care, Inc. , a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2 Insulin Pump with Basal-IQ™ Technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Celeste S Long, MD Po Box 1000 Dept 351, Memphis, TN 38148-0001 Ph: () - | Celeste S Long, MD 1300 Wesley Dr, Memphis, TN 38116 Ph: (901) 395-2618 |
News Archive
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
Children's Health Fund strongly supports the reconciliation bill signed by President Barack Obama implementing positive changes and fixes to the health reform bill he signed earlier this week. This second piece of health reform legislation marks an unprecedented effort to make real and positive change for the health and well-being of children in this country.
Celgene International Sàrl, a subsidiary of Celgene Corporation, announced results from a multi-center Phase I study that explored multiple dosing schedules of oral azacitidine in 23 patients with acute myeloid leukemia (AML), myelodysplastic syndromes or chronic myelomonocytic leukemia (CMML) who were not candidates for other therapies or who had failed previous regimens.
Squire, Sanders & Dempsey is launching Accountable Care Forum - From Volume to Value, a blog dedicated to analysis of the emerging accountable care organization landscape. The launch coincides with regulations issued today by the Centers for Medicare & Medicaid Services.
Tandem Diabetes Care, Inc. , a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2 Insulin Pump with Basal-IQ™ Technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia).
› Verified 3 days ago
Khawaja Muhammad Muddassir, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave, Suite 370, Memphis, TN 38104 Phone: 901-758-7888 Fax: 901-387-5153 | |
Allison Montague, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1955 S 3rd St, Memphis, TN 38109 Phone: 901-515-5800 | |
Dr. Marcia Bradford, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 E Eh Crump Blvd, Memphis, TN 38126 Phone: 901-261-2000 Fax: 901-946-9262 | |
Dr. Aleksandar Jankov, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd, Suite 301, Memphis, TN 38120 Phone: 901-747-9081 Fax: 901-747-9087 | |
Manoj K Jain, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd Ste 209, Memphis, TN 38120 Phone: 901-681-0778 Fax: 901-821-9987 | |
Dr. Karl Weber, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 880 Madison Ave, Memphis, TN 38103 Phone: 901-545-6969 Fax: 901-545-4739 | |
Dr. Pedro Velasquez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1068 Cresthaven Rd Ste 300, Memphis, TN 38119 Phone: 901-683-0024 Fax: 901-683-0086 |